DSIP vs Selank

DSIP (Delta Sleep-Inducing Peptide) is a nonapeptide originally isolated from rabbit cerebral venous blood during electrically induced sleep. Preclinical research has documented its effects on sleep architecture, stress response modulation, and HPA axis regulation. DSIP appears to influence delta-wave sleep patterns and reduce stress-induced corticosterone elevations in study models. Selank is a synthetic heptapeptide derived from tuftsin, an endogenous immunomodulatory peptide. Developed at the Institute of Molecular Genetics in Russia, Selank has been studied for anxiolytic and nootropic properties through GABAergic and serotonergic pathways. Unlike traditional anxiolytics, Selank does not produce sedation or dependence in preclinical models.

DSIP

Structure Nonapeptide
Primary Research Area Sleep architecture, HPA axis
Mechanism Delta sleep modulation, stress response
Sedation Sleep-promoting in study models
Key Biomarkers Corticosterone, delta-wave EEG
Administration Routes Intranasal, intraperitoneal

Selank

Structure Heptapeptide (tuftsin-derived)
Primary Research Area Anxiety, cognition, immunomodulation
Mechanism GABAergic & serotonergic modulation
Sedation No sedation in preclinical models
Key Biomarkers BDNF, serotonin metabolites
Administration Routes Intranasal, intraperitoneal

The Verdict

DSIP and Selank both appear in neurological research but address different physiological domains. DSIP focuses specifically on sleep architecture and stress hormone modulation, with documented effects on delta-wave patterns and HPA axis activity. Selank targets anxiety and cognition through GABA and serotonin pathways without producing sedation. The two are complementary research tools — investigators studying the intersection of sleep, stress, and anxiety may use both in combined protocols.

Explore These Products

DSIP

A naturally occurring nonapeptide first isolated from cerebral venous blood during slow-wave sleep, studied for its role in sleep regulation, stress response, and neuroendocrine modulation.

View Details →

Selank

A synthetic analog of tuftsin studied for its anxiolytic and nootropic effects through GABA modulation and immunomodulatory pathways.

View Details →

DSIP vs Selank — FAQ

Does DSIP cause sleep in research models?
DSIP has been associated with increased delta-wave sleep patterns in preclinical models, though the magnitude varies by species and administration route. Its broader role appears to involve stress response modulation in addition to sleep effects.
Why does Selank not cause sedation?
Despite its anxiolytic profile, Selank works through GABAergic modulation that differs from benzodiazepine binding. Preclinical studies have not documented the sedation, motor impairment, or dependence associated with traditional anxiolytics.
Can they be combined?
Yes. Their mechanisms are non-overlapping, making combined protocols suitable for research at the sleep-anxiety-stress intersection.
What is the regulatory status?
Both are sold as research-use-only compounds for in-vitro and preclinical study models.

References

Primary sources for key clinical and regulatory claims on this page.

  1. Delta sleep-inducing peptide (DSIP): a still unresolved riddle — PubMed / J Neurochem . Foundational review of DSIP discovery and sleep-related research findings.
  2. Anxiolytic activity of peptide drug Selank — PubMed / Bull Exp Biol Med . Primary preclinical source for Selank anxiolytic mechanism through GABAergic modulation.

Keep Researching

Use the surrounding category and guide pages to move from a side-by-side comparison into the broader decision path.

Research Peptides Category
Updated March 2026. This comparison is reviewed for catalog accuracy, sourcing language, and consistency with our public quality standards. It is an educational summary for research reference only. Read our Editorial Standards.

Ready to order?

Pick your product and check out in under 3 minutes.

Shop Now